Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
RIPK3 and kidney disease
Juan Guerrero-Mauvecin; Miguel Fontecha-Barriuso; Ana M. López-Diaz; Alberto Ortiz; Ana B. Sanz;
Nefrologia (English Version). 2024;44:10-22
Upregulation of miR-200a improves ureteral obstruction-induced renal fibrosis via GAB1/Wnt/ß-catenin signaling
XuKai Liu; GeXin Liu; YuZhen Tan; Pan Liu; Le Li;
Nefrologia (English Version). 2023;43 Supl 2:21-31
Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies
William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;
Nefrologia (English Version). 2024;44:796-806